Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Angel Alsina, MD
FL - Tampa General Hospital
Principal Investigator - David J Reich, MD
PA - Drexel University College of Medicine
Principal Investigator - Jan Stange, MD, Ph.D.
Vital Therapies, Inc.
Study Chair - Juan Gallegos-Orozco, MD
UT - University of Utah
Principal Investigator - Julie Thompson, MD
MN - University of Minnesota Medical Center - Twin Cities Campus
Principal Investigator - Kalyan R Bhamidimarri, MD
FL - University of Miami Hospital
Principal Investigator - Lance Stein, MD
GA - Piedmont Atlanta Hospital
Principal Investigator - Lewis W Teperman, MD
NY - New York University Medical Center
Principal Investigator - Linda S Sher, MD
CA - Keck Hospital of USC
Principal Investigator - Marquis Hart, MD
WA - Swedish Medical Center
Principal Investigator - Nikolaos T Pyrsopoulos, MD
NJ - Rutgers University Hospital
Principal Investigator - Nikunj Shah, MD
IL - Rush University Medical Center
Principal Investigator - Parvez Mantry, MD
TX - Methodist Dallas Medical Center - The Liver Institute
Principal InvestigatorKOL profile → - Paul J Gaglio, MD
NY - Montefiore Medical Center
Principal Investigator - Ram Subramanian, MD
GA - Emory University Hospital
Principal Investigator - Rohit Satoskar, MD
DC - Georgetown University Hospital
Principal Investigator - Talal Adhami, MD
OH - Cleveland Clinic Foundation
Principal Investigator - Winfred W Williams, Jr., MD
MA - Massachusetts General Hospital
Principal Investigator - Xaralambos Zervos, DO
FL - Cleveland Clinic Florida
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Keck Hospital of Usc
Los Angeles, California, United States
- Georgetown University Hospital
Washington D.C., District of Columbia, United States
- University of Miami Hospital
Miami, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Cleveland Clinic Floriday
Weston, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Piedmont Atlanta Hospital
Atlanta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Minnesota Medical Center - Twin Cities Campus
Minneapolis, Minnesota, United States
- Rutgers University Hospital
Newark, New Jersey, United States
- New York University Medical Center
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Drexel University College of Medicine
Philadelphia, Pennsylvania, United States
- Methodist Dallas Medical Center - the Liver Institute
Dallas, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Swedish Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2014
- Primary completion
- 30 Sept 2015
- Completion
- 30 Sept 2018
- Last update posted
- 12 Feb 2019
- Registered enrollment
- 8
- Registry id
- NCT01875874
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.